Tokyo Neuroscience Forum

Tokyo Neuroscience Forum
Name	Tokyo Neuroscience Forum
Formation	1998
Headquarters	Tokyo
Leader title	Director

Tokyo Neuroscience Forum The Tokyo Neuroscience Forum is a multidisciplinary consortium based in Tokyo that convenes researchers, clinicians, policymakers, and industry leaders to advance neuroscientific research and translational medicine. It hosts international conferences, funds collaborative projects, and operates training programs linking academic institutions, hospitals, and technology companies across Asia, Europe, and North America. The Forum functions as a hub connecting leading figures and organizations in neuroscience, neurology, psychiatry, and cognitive science.

Overview

The Forum brings together stakeholders from institutions such as University of Tokyo, Keio University, Tokyo Institute of Technology, Osaka University, Tohoku University, Kyoto University, Riken, National Center of Neurology and Psychiatry (Japan), RIKEN Brain Science Institute, Juntendo University, Nagoya University, Hokkaido University, Kobe University, Chiba University, Doshisha University, Nara Institute of Science and Technology, Okinawa Institute of Science and Technology Graduate University, Meiji University, Waseda University, Hitachi, NEC Corporation, Fujitsu, Sony Corporation, Panasonic Corporation, Takeda Pharmaceutical Company, Astellas Pharma, Eisai, Chugai Pharmaceutical Co., GlaxoSmithKline, Pfizer, Novartis, Roche, Bayer, Sanofi, Johnson & Johnson, Eli Lilly and Company, AbbVie, Medtronic, Boston Scientific, GE Healthcare, Siemens Healthineers, Thermo Fisher Scientific, Illumina, and Oxford Nanopore Technologies. The Forum emphasizes translational neuroscience, neurotechnology, neurodegenerative disease, neuroimaging, computational neuroscience, and neuroethics, interfacing with global initiatives such as Human Brain Project, BRAIN Initiative, European Research Council, Wellcome Trust, Howard Hughes Medical Institute, Max Planck Society, CNRS, Karolinska Institutet, Cold Spring Harbor Laboratory, Salk Institute for Biological Studies, Broad Institute, Allen Institute for Brain Science, MNI (Montreal Neurological Institute), Massachusetts Institute of Technology, Harvard University, Stanford University, University College London, Imperial College London, King's College London, University of Cambridge, and University of Oxford.

History and Founding

Founded in 1998, the Forum emerged from collaborations among researchers affiliated with University of Tokyo Hospital, Keio University School of Medicine, Tokyo Metropolitan Institute of Medical Science, National Center for Global Health and Medicine (Japan), RIKEN, Japanese Society of Neurology, Japanese Neuroscience Society, Japanese Society for Neurochemistry, Japan Society for the Promotion of Science, and international partners including NIH, National Institute of Mental Health, Wellcome Trust Sanger Institute, Institut Pasteur, Max Planck Institute for Brain Research, Rudolf Magnus Institute, Cleveland Clinic, Mayo Clinic, and Karolinska University Hospital. Early conferences featured speakers from Eric Kandel, Susumu Tonegawa, Shinya Yamanaka, Ryoji Noyori, Shinichi Takahashi, Masatoshi Takeichi, Shigetada Nakanishi, Yasuo Tonegawa, Kiyoshi Nagai, and representatives from World Health Organization. Institutional agreements and memoranda of understanding were signed with Ministry of Education, Culture, Sports, Science and Technology (Japan), METI, and regional bodies to foster translational pipelines.

Organization and Governance

The Forum is governed by a board comprising chairs and directors from University of Tokyo, Keio University, Riken, Tohoku University, Kyoto University, Osaka University, Nagoya University, Hokkaido University, Okinawa Institute of Science and Technology Graduate University, industry representatives from Takeda Pharmaceutical Company, Eisai, Sony Corporation, NEC Corporation, and international liaisons from NIH, Wellcome Trust, European Commission, UNESCO, World Health Organization, and funding bodies such as Japan Agency for Medical Research and Development (AMED), Japan Society for the Promotion of Science (JSPS), National Science Foundation, European Research Council, and National Natural Science Foundation of China. Advisory committees include experts from Max Planck Society, Karolinska Institutet, Massachusetts General Hospital, Johns Hopkins University, Columbia University, Yale University, University of California, San Francisco, Princeton University, University of Chicago, ETH Zurich, École Polytechnique Fédérale de Lausanne, Weizmann Institute of Science, Tel Aviv University, and McGill University.

Conferences and Programs

Annual flagship meetings draw delegations from Society for Neuroscience, Federation of European Neuroscience Societies (FENS), Asia-Pacific Neurochemistry Consortium, International Neuroethics Society, World Congress of Neurology, Alzheimer's Association, Parkinson's Foundation, Epilepsy Foundation, American Neurological Association, European Academy of Neurology, International Brain Research Organization (IBRO), Human Frontier Science Program, Society for Cognitive Neuroscience, Cognitive Neuroscience Society, and professional societies in neurosurgery such as American Association of Neurological Surgeons and World Federation of Neurosurgical Societies. Programs include symposia on connectomics featuring work from Blue Brain Project, workshops on neuroprosthetics with teams from DARPA, hackathons with Google DeepMind, OpenAI, and industry days featuring Sony Corporation and Fujitsu. The Forum runs fellowship programs in partnership with Fulbright Program, Rhodes Trust, Japan Society for the Promotion of Science (JSPS), and international exchange schemes with EMBO.

Research Initiatives and Collaborations

Research initiatives span projects in neurodegeneration (Alzheimer's, Parkinson's), neurodevelopmental disorders (autism spectrum disorder), neuroimaging, electrophysiology, and computational modeling. Collaborations involve laboratories at Salk Institute for Biological Studies, Broad Institute, Allen Institute for Brain Science, RIKEN, University of Tokyo, Keio University, Tohoku University, Kyoto University, Max Planck Institute for Brain Research, Cold Spring Harbor Laboratory, Howard Hughes Medical Institute, Wellcome Trust Sanger Institute, CNRS, INSERM, NIH, European Commission, China Academy of Sciences, Korea Advanced Institute of Science and Technology, Stanford University, MIT, Harvard Medical School, UCSF, Johns Hopkins Hospital, Massachusetts General Hospital, Karolinska Institutet, Imperial College London, UCL Queen Square Institute of Neurology, and industrial R&D units at Takeda Pharmaceutical Company, Eisai, Roche, Novartis, Pfizer, Illumina, and Siemens Healthineers. Projects include brain-computer interface trials, multi-omics studies using platforms from Illumina and Oxford Nanopore Technologies, longitudinal cohort studies modeled after Framingham Heart Study, and neuroinformatics initiatives interoperable with resources like Human Brain Project and Alzheimers Disease Neuroimaging Initiative (ADNI).

Education and Outreach

Educational activities include graduate coursework, postgraduate fellowships, MOOCs co-developed with edX, Coursera, and partner universities such as MIT, Stanford University, Keio University, University of Tokyo, and public lectures in collaboration with Science Museum, London, Smithsonian Institution, Tokyo National Museum, United Nations University, Japan Foundation, and outreach to patient advocacy groups like Alzheimer's Association, Parkinson's Foundation, Autism Speaks, Epilepsy Foundation, and Multiple Sclerosis Society. The Forum runs teacher training with UNESCO and community engagement via science festivals associated with World Science Festival and regional events coordinated with Asia Pacific Science Technology and Innovation Cooperation (APSTIC).

Impact and Recognition

The Forum's outputs have been cited in policy advisories by Ministry of Health, Labour and Welfare (Japan), white papers from OECD, reports to G7, and have informed clinical trials at Cleveland Clinic, Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and Imperial College Healthcare NHS Trust. Awards and honors to associated researchers include Nobel Prize in Physiology or Medicine, Lasker Award, Breakthrough Prize in Life Sciences, Japan Prize, Asahi Prize, Prince Mahidol Award, and fellowships from Royal Society, National Academy of Sciences (United States), Academia Europaea, and Japan Academy. The Forum has been profiled in outlets such as Nature (journal), Science (journal), The Lancet, The New England Journal of Medicine, The New York Times, The Guardian, and NHK.

Category:Neuroscience organizations